# Individualizing Anti-TNF Therapy in Patients With Inflammatory Bowel Disease

> **NCT07644117** · — · RECRUITING · sponsor: **Shmuel Kivity, MD** · enrollment: 40 (estimated)

## Conditions studied

- IBD (Inflammatory Bowel Disease)
- Crohn Disease (CD)
- Ulcerative Colitis (UC)

## Interventions

- **OTHER:** This is an observational study with no intervention. Patients will receive anti- TNF therapy as part of their standard care

## Key facts

- **NCT ID:** NCT07644117
- **Lead sponsor:** Shmuel Kivity, MD
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-04
- **Primary completion:** 2028-05
- **Final completion:** 2028-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07644117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07644117, "Individualizing Anti-TNF Therapy in Patients With Inflammatory Bowel Disease". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07644117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*